Joanne Donovan
Vermogen: 350 175 $ op 30-09-2026
Vermogen: 350 175 $ op 30-09-2026
Joanne M.
Donovan is currently Chief Medical Officer at Edgewise Therapeutics, Inc. since 2021.
Formerly, Dr. Donovan was Medical Director at GelTex Pharmaceuticals, Inc., Chief Medical Officer & SVP-Clinical Development at Astria Therapeutics, Inc. from 2011 to 2021, Associate Clinical Professor at Harvard Medical School, and Vice President-Clinical Development at Genzyme Corp.
from 1998 to 2011.
Education includes undergraduate, graduate, and doctorate degrees from Massachusetts Institute of Technology and a doctorate degree from Harvard Medical School.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 13-08-2026 | 8.625 ( 0,01% ) | 350 175 $ | 30-09-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| EDGEWISE THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 27-04-2021 |
| Bedrijven | Functie | Einde |
|---|---|---|
| ASTRIA THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 23-04-2021 |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Hoofd Techniek/Wetenschap/O&O | 01-07-2011 |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
GelTex Pharmaceuticals, Inc.
GelTex Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops non-absorbed, polymer-based pharmaceuticals | Hoofd Techniek/Wetenschap/O&O | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 6 |
|---|---|
GelTex Pharmaceuticals, Inc.
GelTex Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops non-absorbed, polymer-based pharmaceuticals | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Astria Therapeutics, Inc.
Astria Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel therapeutics for allergic & immunologic diseases | Health Technology |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Edgewise Therapeutics, Inc.
Edgewise Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapies for skeletal muscle diseases | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau